Vanguard Group Inc. lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,795,894 shares of the financial services provider’s stock after acquiring an additional 563,460 shares during the quarter. Vanguard Group Inc. owned about 6.73% of CME Group worth $2,854,958,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Public Sector Pension investment Board increased its stake in shares of CME Group by 21.7% during the second quarter. Public Sector Pension investment Board now owns 93,810 shares of the financial services provider’s stock valued at $11,749,000 after acquiring an additional 16,700 shares during the period. UBS Asset Management Americas Inc. increased its stake in shares of CME Group by 6.8% during the second quarter. UBS Asset Management Americas Inc. now owns 1,132,380 shares of the financial services provider’s stock valued at $141,819,000 after acquiring an additional 72,531 shares during the period. Quantitative Investment Management LLC acquired a new position in shares of CME Group during the second quarter valued at approximately $38,411,000. New York State Common Retirement Fund increased its stake in shares of CME Group by 1.2% during the second quarter. New York State Common Retirement Fund now owns 967,419 shares of the financial services provider’s stock valued at $121,160,000 after acquiring an additional 11,899 shares during the period. Finally, Investec Asset Management PTY Ltd increased its stake in shares of CME Group by 48.6% during the second quarter. Investec Asset Management PTY Ltd now owns 11,921 shares of the financial services provider’s stock valued at $1,491,000 after acquiring an additional 3,898 shares during the period. Institutional investors and hedge funds own 82.64% of the company’s stock.
CME Group Inc. (CME) traded up 0.93% on Wednesday, reaching $133.04. 448,920 shares of the company’s stock traded hands. The firm has a market capitalization of $45.22 billion, a PE ratio of 27.16 and a beta of 0.72. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $133.54. The firm’s 50 day moving average price is $126.73 and its 200 day moving average price is $122.14.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. During the same period in the prior year, the business posted $1.14 earnings per share. CME Group’s revenue was up 2.1% compared to the same quarter last year. On average, analysts predict that CME Group Inc. will post $4.81 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a $0.66 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 2.00%. CME Group’s dividend payout ratio is currently 53.99%.
A number of research firms recently commented on CME. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Jefferies Group LLC reiterated a “buy” rating and set a $134.00 price objective (up previously from $128.00) on shares of CME Group in a research note on Monday, July 17th. Royal Bank Of Canada raised their price objective on shares of CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a research note on Tuesday, June 20th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Finally, Barclays PLC began coverage on shares of CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 price objective on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. CME Group has a consensus rating of “Buy” and an average target price of $132.56.
COPYRIGHT VIOLATION WARNING: “CME Group Inc. (CME) Shares Bought by Vanguard Group Inc.” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://ledgergazette.com/2017/09/20/cme-group-inc-cme-shares-bought-by-vanguard-group-inc.html.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $124.50, for a total value of $311,250.00. Following the transaction, the chief financial officer now directly owns 38,495 shares in the company, valued at $4,792,627.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Terrence A. Duffy sold 21,815 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the completion of the transaction, the chairman now owns 110,711 shares in the company, valued at $13,715,985.79. The disclosure for this sale can be found here. Insiders sold 48,244 shares of company stock worth $6,021,890 over the last 90 days. 0.57% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.